Showing 20,461 - 20,480 results of 48,847 for search '(( significant ((time decrease) OR (use increased)) ) OR ( significant decrease decrease ))', query time: 0.73s Refine Results
  1. 20461
  2. 20462
  3. 20463
  4. 20464
  5. 20465
  6. 20466
  7. 20467

    Experimental scenarios. by Elisabeth Jambor (20570623)

    Published 2025
    “…The most significant increase in patient waiting times occurs when only two radiation therapists are available. …”
  8. 20468

    Scenario variables. by Elisabeth Jambor (20570623)

    Published 2025
    “…The most significant increase in patient waiting times occurs when only two radiation therapists are available. …”
  9. 20469

    Literature search protocol. by Elisabeth Jambor (20570623)

    Published 2025
    “…The most significant increase in patient waiting times occurs when only two radiation therapists are available. …”
  10. 20470

    Floor plan of the radiotherapy centre model. by Elisabeth Jambor (20570623)

    Published 2025
    “…The most significant increase in patient waiting times occurs when only two radiation therapists are available. …”
  11. 20471

    Key performance indicators. by Elisabeth Jambor (20570623)

    Published 2025
    “…The most significant increase in patient waiting times occurs when only two radiation therapists are available. …”
  12. 20472

    Low and high COVID-19 phases. by Elisabeth Jambor (20570623)

    Published 2025
    “…The most significant increase in patient waiting times occurs when only two radiation therapists are available. …”
  13. 20473

    Results from the structured literature review. by Elisabeth Jambor (20570623)

    Published 2025
    “…The most significant increase in patient waiting times occurs when only two radiation therapists are available. …”
  14. 20474

    Data from: Using spatially rich datasets to assess the influence of channel characteristics on biogeochemical behavior in agricultural watersheds by BRENT DALZELL (20147766)

    Published 2024
    “…</p><p dir="ltr"><b>Plain Language Summary</b></p><p dir="ltr">Many farmlands have been altered to drain water and increase crop production. These changes often involve straightening natural stream channels, which reduces their ability to use nutrients and carbon. …”
  15. 20475

    Supplementary Material for: Cardiovascular and Renal Outcomes with Ertugliflozin by Baseline Use of Renin–Angiotensin–Aldosterone System Inhibitors or Diuretics, Including Mineralo... by Cherney D.Z.I. (8091425)

    Published 2025
    “…Statistically significant interactions for a first event of hospitalization for heart failure (HHF) or CV death, and of HHF (alone), were observed with baseline use of diuretics, including loop diuretics, with an increased benefit of ertugliflozin treatment versus placebo. …”
  16. 20476

    Inclusion flow chart. by Alice L. J. Carr (21807686)

    Published 2025
    “…Conversely, higher purity and larger eTLV were associated with smaller increases in pressure. A significant interaction term indicated that the effect that PCV has on pressure change may be moderated at higher purities. …”
  17. 20477
  18. 20478

    Table 1_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.xlsx by Satoko Watanabe (59124)

    Published 2025
    “…In the Weibull analysis for pemafibrate, the shape parameter (β) was 1.59 [1.17–2.56], indicating an increasing trend in ADE reporting with continued pemafibrate use.…”
  19. 20479

    Table 3_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.xlsx by Satoko Watanabe (59124)

    Published 2025
    “…In the Weibull analysis for pemafibrate, the shape parameter (β) was 1.59 [1.17–2.56], indicating an increasing trend in ADE reporting with continued pemafibrate use.…”
  20. 20480

    Table 4_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.xlsx by Satoko Watanabe (59124)

    Published 2025
    “…In the Weibull analysis for pemafibrate, the shape parameter (β) was 1.59 [1.17–2.56], indicating an increasing trend in ADE reporting with continued pemafibrate use.…”